Torrent Pharma receives approval for Memantine Hydrochloride (along with Alembic, Jubilant, Unichem, Macleods, Aurobindo and Silarx)..
As mentioned by Ankit in his file on torrent key molecules, Memantine has a $1.4 bn size, though impact on Torrent will not be much as it will be a late entrant with four players already in the market and these 7 getting approval, leading to a competitive market.
Anybody has done any research on Sutlej textiles and specifically have any input on the management?
manish : apologies - will refrain from sharing in future . thanks for pointing out forum guidelines
Thanks Hitesh and Raj for detailed response. Now, it makes sense why abilify contribution will go down from 2017 on-wards.
Rajesh,
as Raj mentioned price erosion should be expected as more and more players get approval. Plus market share also will get reduced over a time.
The main thing here is to see how much the company makes in the limited competition period. And thats where players like torrent have got lucky and were in the right place at the right time. Alembic also benefitted but since it doesnt have its own front end marketing network in US, (which torrent has), it will have to share profits with marketing partner.
hitesh ji,
what is your view on page industries now at 80 PE?
Thanks for pointing, will check
Thanks Anindya for correcting me. I missed the point.
@raj This is a 50:50 JV so you have to divide 550 by 2.You can refer to Q3 concall transcript as well (I made a comment earlier on the same topic, you can check that one too)
When abilify was launched then there were only 4 players. Now Apotex has joined as a 5th player. Couple of days back Aurobindo also got approval. Lupin and Sun have tentative approval. Hence prices should crack, but how much that only time will tell.